| MDACC Prognostic Score |
FANG Phase I Months Survival n = 31* |
MDA Months Survival (Wheler, et al.) n = 1,181 |
| 0 Low Risk |
34.7 |
24.0 |
| 1 Low-intermediate Risk |
25.0 |
15.2 |
| 2 Intermediate Risk |
11.8 |
8.4 |
| 3 High-Intermediate Risk |
26.1 |
6.2 |
| 4 High Risk |
6.2 |
4.1 |
*4 patients did not have complete medical records access in long term follow up |
